2Luz Ma Adriana BP, Jose Luis CM, Jose AV, et al. The HELPP syndrome- evidence of a possible systemic inflammatory response in pre-eclampsia?Ginecol Obstet Mex, 2002,70(6): 328-337.
3Dekker GA.Etiology and pathogenesis of preeclampsia:Current concepts.Am J Obstet Gynecol, 1998,179(5): 1359-1375.
4Granger JP, Alexander BT, Llinas MT,et al. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension, 2001, 38(3 Pt 2): 718-722.
5Merviel P, Evain Brion D, Challier JC, et al. The molecular basis of embryo implantation in humans. Zentralbl Gynakol, 2001, 123(6):328-339.
6Gaunt G, Ramin K. Immunological tolerance of the human fetus. Am J Perinatol, 2001,18(6): 299-312.
7King A, Burrows T, Verma S, et al . Human uterine lymphocytes.Hum Reprod Update, 1998,4(5):480-485.
8Xu C,Mao D,Holers VM ,et al. A Critical Role for Murine Complement Regulator Crry in Fetomatemal Tolerance. Science, 2000,287( 5452 ) :498-501.
9Reister F, Frank HG, Kingdom JC,et al. Maerophage-indueed apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest, 2001, 81(8): 1143-1152.
10Mellembaken JR, Aukrust P, Olafsen MK, et al. Activation of leukocytes during the uteroplacental passage in preeclampsia. Hypertension, 2002,39(1): 155-160.
